warfarin and Lymphoma--B-Cell

warfarin has been researched along with Lymphoma--B-Cell* in 1 studies

Other Studies

1 other study(ies) available for warfarin and Lymphoma--B-Cell

ArticleYear
Remission of severe antiphospholipid syndrome associated with non-Hodgkin's B-cell lymphoma after combined treatment with rituximab and chemotherapy.
    Haematologica, 2005, Volume: 90 Suppl

    The association of lymphoid neoplasms and antiphospolipid antibodies (APA), with or without thromboembolic complications, has been reported in several cases. We describe one case of B-cell non-Hodgkinís lymphoma (NHL) in which the combination of rituximab with standard chemotherapy led to the complete remission of a severe hypercoagulable state associated with APA.

    Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Antiphospholipid Syndrome; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Heparin; Humans; Immunotherapy; Lymphoma, B-Cell; Male; Middle Aged; Prednisone; Pulmonary Embolism; Recurrence; Remission Induction; Rituximab; Splenectomy; Thrombophilia; Thrombophlebitis; Vincristine; Warfarin

2005